Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04086264
Title IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications

acute myeloid leukemia

Therapies

IMGN632

IMGN632 + Venetoclax

Azacitidine + IMGN632

Azacitidine + IMGN632 + Venetoclax

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.